Info Sheet

Pandemic Response Assessment

The COVID-19 pandemic forced immediate implementation of large-scale crisis response initiatives in global clinical trials. As life science companies prepare to move into the next stage of recovery, now is the time to assess the changes implemented and refine continuity plans to ensure regulatory compliance, participant safety, and organizational preparedness now and into the future.

Advarra's pandemic response assessment helps research and development teams:
  • Ensure seamless health authority inspection readiness
  • Determine how well pandemic response activities were adapted and in accordance with local health authority COVID-19-specific guidance, global regulatory guidance, and industry best practices
  • Identify compliance gaps and potential remediation opportunities
  • Ensure successful protocol deviation management
  • Audit new capabilities and technologies, including telemedicine, home health visits, wearables, remote data review, and more
  • Evaluate post-marketing adverse event safety reporting
  • Determine the effectiveness of the company's governance and COVID-19 decision making

Download the info sheet

Who should watch?

text goes here

CEU Credits

text goes here

Certificate of Attendance

text goes here

Time: 1 p.m. ET, 12 p.m. CT, 10 a.m. PT
Duration: 1 hour

Download Now